News | Flat Panel Displays | October 14, 2015

5MP, 21-inch color LED-backlit display offers high resolution and advanced features

Quest International, Totoku CCL550i2 diagnostic display, FFDM approval, full-field digital mammography, breast imaging applications

Image courtesy of Totoku


October 14, 2015 — Quest International Inc. announced the availability of the Totoku CCL550i2 color diagnostic display from JVC Kenwood. The newly announced 5MP (megapixel) display is the first color 5MP diagnostic display that has been granted 510(k) full-field digital mammography (FFDM) approval by the U.S. Food and Drug Administration for use in all digital mammography applications.

The CCL550i2 is a 5-megapixel high-bright, color LED-backlit LCD designed for both picture archiving and communication system (PACS) and breast imaging, eliminating the need for other multi-head display configurations or needing to move to another workstation to view additional studies.

Features of the Totoku CCL550i2 include:
            - 5MP high resolution color diagnostic display
            - 21.3-inch color TFT IPS technology display panel
            - LED backlight technology
            - 1000 cd/m² maximum luminance, calibrated to 410 cd/m² luminance
            - Front luminance sensors
            - Dual input (DisplayPort and DVI-D) interface

The Totoku CCL550i2 is currently available from Quest International. The unit is backed by Quest International through a five-year warranty. Available exclusively from Quest International is an optional advanced exchange warranty option on the monitor.

Located in Irvine, California, Quest International serves as a master distributor and authorized service center for Totoku Medical Displays in North America.

For more information: www.totoku.com


Related Content

News | Breast Imaging

March 10, 2026 — QT Imaging Holdings has received U.S. Food and Drug Administration (FDA) 510(k) clearance for an ...

Time March 13, 2026
arrow
News | Women's Health

March 4, 2026 — QT Imaging Holdings recently announced that Mary W. Yamashita, MD will serve as medical advisor to the ...

Time March 06, 2026
arrow
News | Radiation Oncology

March 4, 2026 — Lunit has announced that 21 studies featuring its AI solutions will be presented at the European ...

Time March 05, 2026
arrow
News | Women's Health

Feb.23, 2026 — The first clinical patient received a Clairity Breast cancer risk score, marking a historic milestone in ...

Time February 23, 2026
arrow
News | Breast Biopsy Systems

Feb. 18, 2026 — Mammotome, a Danaher company, has introduced the Mammotome Prima MR Dual Vacuum-Assisted Breast Biopsy ...

Time February 18, 2026
arrow
News | Breast Imaging

Feb. 16, 2026 — Rising demand for breast cancer screening and diagnostics is outpacing the supply of available breast ...

Time February 17, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Feb. 5, 2026 — Eyas Medical Imaging, Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its ...

Time February 06, 2026
arrow
News | Ultrasound Women's Health

Feb. 5, 2026 — BrightHeart, a global provider of AI-driven prenatal ultrasound, has announced the availability of its B ...

Time February 05, 2026
arrow
News | Radiation Therapy

Feb. 4, 2026 — On World Cancer Day (02.04.26), the American Society for Radiation Oncology (ASTRO) and the European ...

Time February 04, 2026
arrow
News | Radiology Imaging

Feb. 4, 2026 — The Royal College of Radiologists (RCR) has issued its initial reaction to the British government's ...

Time February 04, 2026
arrow
Subscribe Now